Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does METOPROLOL Cause Product administration error? 109 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 109 reports of Product administration error have been filed in association with METOPROLOL (metoprolol succinate). This represents 0.3% of all adverse event reports for METOPROLOL.

109
Reports of Product administration error with METOPROLOL
0.3%
of all METOPROLOL reports
5
Deaths
78
Hospitalizations

How Dangerous Is Product administration error From METOPROLOL?

Of the 109 reports, 5 (4.6%) resulted in death, 78 (71.6%) required hospitalization, and 10 (9.2%) were considered life-threatening.

Is Product administration error Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for METOPROLOL. However, 109 reports have been filed with the FAERS database.

What Other Side Effects Does METOPROLOL Cause?

Drug ineffective (3,434) Dyspnoea (3,428) Dizziness (3,275) Hypotension (3,213) Completed suicide (2,959) Fatigue (2,784) Off label use (2,580) Toxicity to various agents (2,404) Bradycardia (2,024) Nausea (1,894)

What Other Drugs Cause Product administration error?

HYDROXYPROGESTERONE CAPROATE (972) ACETAMINOPHEN (666) CENEGERMIN-BKBJ (613) LEUPROLIDE (595) EVOLOCUMAB (565) ADALIMUMAB (543) METHYLPHENIDATE (414) OLMESARTAN MEDOXOMIL (314) ASPIRIN (241) SECUKINUMAB (225)

Which METOPROLOL Alternatives Have Lower Product administration error Risk?

METOPROLOL vs METRELEPTIN METOPROLOL vs METRONIDAZOLE METOPROLOL vs METRONIDAZOLE\METRONIDAZOLE METOPROLOL vs METYRAPONE METOPROLOL vs MEXILETINE

Related Pages

METOPROLOL Full Profile All Product administration error Reports All Drugs Causing Product administration error METOPROLOL Demographics